Shiaw‐Yih Lin

8.6k total citations · 3 hit papers
78 papers, 6.3k citations indexed

About

Shiaw‐Yih Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shiaw‐Yih Lin has authored 78 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 40 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Shiaw‐Yih Lin's work include DNA Repair Mechanisms (34 papers), PARP inhibition in cancer therapy (13 papers) and Cancer-related Molecular Pathways (11 papers). Shiaw‐Yih Lin is often cited by papers focused on DNA Repair Mechanisms (34 papers), PARP inhibition in cancer therapy (13 papers) and Cancer-related Molecular Pathways (11 papers). Shiaw‐Yih Lin collaborates with scholars based in United States, China and Taiwan. Shiaw‐Yih Lin's co-authors include Mien‐Chie Hung, Weiya Xia, Stephen J. Elledge, Yong Wen, Ka Yin Kwong, Kaiyi Li, Guang Peng, Hui Dai, Lilly Bourguignon and Keishi Makino and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Shiaw‐Yih Lin

77 papers receiving 6.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nuclear localization of EGF receptor and its potential new role as a transcription factor

2001 863 citations Shiaw‐Yih Lin, Keishi Makino et al. Nature Cell Biology profile →
β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

2000 672 citations Shiaw‐Yih Lin, Weiya Xia et al. profile →
Tumor microenvironment: barrier or opportunity towards effective cancer therapy

2022 212 citations Shiaw‐Yih Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shiaw‐Yih Lin United States	36	4.8k	2.4k	1.1k	624	589	78	6.3k
Takehiko Kamijo Japan	37	5.1k 1.1×	3.2k 1.3×	1.0k 1.0×	574 0.9×	462 0.8×	114	7.1k
Dawn E. Quelle United States	30	4.5k 0.9×	3.7k 1.5×	725 0.7×	896 1.4×	479 0.8×	70	6.5k
Earlene M. Schmitt United States	10	5.0k 1.0×	4.0k 1.7×	1.1k 1.0×	691 1.1×	613 1.0×	13	7.5k
Dung‐Fang Lee United States	36	4.9k 1.0×	1.6k 0.6×	1.4k 1.3×	416 0.7×	368 0.6×	87	6.3k
David O. Ferguson United States	40	6.2k 1.3×	2.4k 1.0×	1.4k 1.3×	572 0.9×	645 1.1×	67	7.6k
Brad St. Croix United States	32	4.1k 0.9×	1.8k 0.7×	1.4k 1.3×	697 1.1×	444 0.8×	58	6.0k
Catrin Pritchard United Kingdom	36	3.9k 0.8×	1.9k 0.8×	594 0.5×	845 1.4×	493 0.8×	88	5.9k
Marie Classon United States	27	4.4k 0.9×	2.1k 0.9×	1.1k 1.0×	489 0.8×	430 0.7×	43	5.9k
Steven B. McMahon United States	42	6.5k 1.4×	2.2k 0.9×	1.9k 1.8×	505 0.8×	533 0.9×	77	8.1k
Domenico Delia Italy	43	4.2k 0.9×	2.5k 1.0×	1.2k 1.1×	453 0.7×	565 1.0×	125	6.9k

Countries citing papers authored by Shiaw‐Yih Lin

Since Specialization

Citations

This map shows the geographic impact of Shiaw‐Yih Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiaw‐Yih Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiaw‐Yih Lin more than expected).

Fields of papers citing papers by Shiaw‐Yih Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiaw‐Yih Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiaw‐Yih Lin. The network helps show where Shiaw‐Yih Lin may publish in the future.

Co-authorship network of co-authors of Shiaw‐Yih Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shiaw‐Yih Lin. A scholar is included among the top collaborators of Shiaw‐Yih Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiaw‐Yih Lin. Shiaw‐Yih Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grippin, Adam, N. Li, Christian Braun, et al.. (2025). LBA54 SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade. Annals of Oncology. 36. S1598–S1598.

McGrail, Daniel J., Kaiyi Li, Faye M. Johnson, et al.. (2024). Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial.. Journal of Clinical Oncology. 42(16_suppl). 6059–6059. 1 indexed citations

Mitani, Yoshitsugu, Luana Guimarães de Sousa, Mario L. Marques‐Piubelli, et al.. (2023). Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance. Modern Pathology. 37(1). 100371–100371. 3 indexed citations

Sousa, Luana Guimarães de, Daniel J. McGrail, Felippe Lazar Neto, et al.. (2023). Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors. Clinical Cancer Research. 29(16). 3162–3171. 12 indexed citations

Sousa, Luana Guimarães de, Daniel J. McGrail, Kaiyi Li, et al.. (2022). Spontaneous tumor regression following COVID-19 vaccination. Journal for ImmunoTherapy of Cancer. 10(3). e004371–e004371. 30 indexed citations

Lindemann, Antje, Ameeta A. Patel, Lin Tang, et al.. (2021). Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Molecular Cancer Therapeutics. 20(7). 1257–1269. 18 indexed citations

McGrail, Daniel J., Patrick G. Pilié, Hui Dai, et al.. (2021). Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers. Science Translational Medicine. 13(617). eabe6201–eabe6201. 22 indexed citations

McGrail, Daniel J., Ming Sun, Dan Qi, et al.. (2020). Integrated Genomic Characterization of the Human Immunome in Cancer. Cancer Research. 80(21). 4854–4867. 10 indexed citations

Ferrarotto, Renata, Yoshitsugu Mitani, Daniel J. McGrail, et al.. (2020). Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clinical Cancer Research. 27(3). 852–864. 87 indexed citations

10.

Fang, Yong, Jun‐Jie Yin, Jian Chen, et al.. (2017). Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Science Translational Medicine. 9(392). 170 indexed citations

11.

Mo, Wei, Qingxin Liu, Curtis Chun-Jen Lin, et al.. (2015). mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer. Clinical Cancer Research. 22(7). 1699–1712. 90 indexed citations

12.

Jiang, Yuhui, Xu Qian, Jianfeng Shen, et al.. (2015). Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nature Cell Biology. 17(9). 1158–1168. 164 indexed citations

13.

Peng, Yang, Hui Dai, Wenge Wang, et al.. (2014). TUSC4 Functions as a Tumor Suppressor by Regulating BRCA1 Stability. Cancer Research. 75(2). 378–386. 26 indexed citations

14.

Zhang, Bo, Wenge Wang, Hui Dai, et al.. (2013). BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer. Carcinogenesis. 34(10). 2271–2280. 13 indexed citations

15.

Peng, Guang, Hui Dai, Wei Zhang, et al.. (2012). Human Nuclease/Helicase DNA2 Alleviates Replication Stress by Promoting DNA End Resection. Cancer Research. 72(11). 2802–2813. 64 indexed citations

16.

Ko, Song Yi, et al.. (2012). Dual Functions of the Homeoprotein DLX4 in Modulating Responsiveness of Tumor Cells to Topoisomerase II-Targeting Drugs. Cancer Research. 73(2). 1000–1010. 20 indexed citations

17.

Kim, Hyeung, Ok-Hee Lee, Huawei Xin, et al.. (2009). TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nature Structural & Molecular Biology. 16(4). 372–379. 105 indexed citations

18.

Lin, Shiaw‐Yih, Keishi Makino, Weiya Xia, et al.. (2001). Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biology. 3(9). 802–808. 863 indexed citations breakdown →

19.

Zhou, Binhua P., Mickey C.‐T. Hu, Stephanie A. Miller, et al.. (2000). HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway. Journal of Biological Chemistry. 275(11). 8027–8031. 322 indexed citations

20.

Lin, Shiaw‐Yih, et al.. (1996). Cell Cycle-Regulated Association of E2F1 and Sp1 Is Related to Their Functional Interaction. Molecular and Cellular Biology. 16(4). 1668–1675. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact